BioLineRx Announces Initiation of Triple Combination Arm of Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer Under Immuno-Oncology Collaboration
Stock Information for BioLineRx Ltd.
Loading
Please wait while we load your information from QuoteMedia.